CEDEMU
ActiveSummary
CEDEMU has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €47,691 and a net result of €24,943. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 14% of 19918 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability80▲+24
Solvency43▼-12
Growth78▲+26
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €3,000 at 30 days acceptable
Liquidity short (current ratio 0.5 against 1.28 in 2023; short-term debt: 66.4% and cash: 15.6% of total assets), and 82.5% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
17.5%
Return on assets
9.2%
Age of the figures
21 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 14% of 19918 sector peers (2024).
NBB · sector comparisonPosition among 19918 sector peers
Solvency
better than 14%
← weakest
strongest →
lowers risk · Growing equity
Reported equity is higher than in 2022 and did not fall compared with 2023. These amounts do not establish the cause of the change.
NBB · annual accounts 2024Equity per financial year
18192021222324
2018 to 2024 · latest year €47,691
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 31-08-2025, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
31 d late
2023
30 d late
2022
60 d late
2021
31 d late
2020
31 d late
2019
100 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 47 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, micro schema
Equity
€47,691▲ 110%
2023 · €22,748
Total assets
€272,420▲ 257%
2023 · €76,204
Net result
€24,943
2023 · -€7,720
Working capital
-€90,250
2023 · €13,856
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€22,663▼ 7.9%-€7,684-€6,766▲ 11.9%-€6,969▼ 3.0%€38,390
Net result€13,856▼ 9.2%-€9,225-€8,034▲ 12.9%-€7,720▲ 3.9%€24,943
Equity€35,328▲ 64.5%€26,102▼ 26.1%€18,068▼ 30.8%€22,748▲ 25.9%€47,691▲ 110%
Total assets€147,166▼ 5.2%€119,497▼ 18.8%€94,881▼ 20.6%€76,204▼ 19.7%€272,420▲ 257%
Debt€111,839▼ 16.4%€93,394▼ 16.5%€76,812▼ 17.8%€53,456▼ 30.4%€224,730▲ 320%
Working capital€23,895▲ 144%€15,764▼ 34.0%€12,123▼ 23.1%€13,856▲ 14.3%-€90,250
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2024: €38,390 after a loss of €6,969 in 2023, the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €272,420
Fixed assets
€181,760 ▲ 1,369%
Current assets
€90,660 ▲ 42.0%
Equity and liabilities €272,420
Equity
€47,691 ▲ 110%
Debt
€224,730 ▲ 320%
Debt's share of the balance-sheet total rises from 70.1% to 82.5%. Equity and debt are higher.
Key figures and ratios
EBITDA
€79,233▲
2023 · €5,438
Cash flow
€65,786▲
2023 · €4,686
Current ratio
0.50▼
2023 · 1.28
Debt to equity
4.71▲
2023 · 2.35
ROE
52.3%▲
2023 · -33.9%
ROA
9.2%▲
2023 · -10.1%
Interest coverage
26.80▲
2023 · 7.75
Debt ≤ 1 year
€180,909▲
2023 · €49,972
Debt > 1 year
€43,812▲
2023 · €3,451
Income taxes
€10,705▲
2023 · €214
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 5,049 companies that looked in July 2024 the way this one looks now, 1.5% went bankrupt within 24 months and 96% are still going.
- Micro
- 10 to 20 years old
- solvency 10 to 30%
- a profit of 5% of the balance sheet or more
1.5%
went bankrupt
2.3%
stopped otherwise
96%
still going
A further 0.4% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.6% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 5,049 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €19,490 | €19,207 | €19,026 | €12,407 | €40,843 | ▲ 229% |
| Other operating charges640/8 | - | €5,103 | €1,117 | €1,030 | €4,398 | ▲ 327% |
| Gross operating margin9900 | €43,091 | €16,626 | €13,377 | €6,467 | €83,631 | ▲ 1,193% |
| Operating profit (loss)9901 | €22,663 | -€7,684 | -€6,766 | -€6,969 | €38,390 | ▲ 651% |
| Financial income75/76B | - | €0 | €0 | €165 | €215 | ▲ 30.5% |
| Recurring financial income75 | €0 | €0 | €0 | €165 | €215 | ▲ 30.5% |
| Financial charges65/66B | - | €1,330 | €1,014 | €701 | €2,957 | ▲ 321% |
| Recurring financial charges65 | €1,587 | €1,330 | €1,014 | €701 | €2,957 | ▲ 321% |
| Profit (loss) for the period before taxes9903 | €21,076 | -€9,013 | -€7,780 | -€7,506 | €35,648 | ▲ 575% |
| Income taxes67/77 | €7,220 | €212 | €254 | €214 | €10,705 | ▲ 4,899% |
| Profit (loss) for the period9904 | €13,856 | -€9,225 | -€8,034 | -€7,720 | €24,943 | ▲ 423% |
| Profit (loss) for the period to be appropriated9905 | €13,856 | -€9,225 | -€8,034 | -€7,720 | €24,943 | ▲ 423% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €147,166 | €119,497 | €94,881 | €76,204 | €272,420 | ▲ 257% |
| Formation expenses20 | - | - | - | €0 | €0 | - |
| Fixed assets21/28 | €61,317 | €42,109 | €23,083 | €12,376 | €181,760 | ▲ 1,369% |
| Intangible fixed assets21 | €46,000 | €34,000 | €22,000 | €10,000 | €103,500 | ▲ 935% |
| Tangible fixed assets22/27 | €15,292 | €8,084 | €1,058 | €2,351 | €78,235 | ▲ 3,227% |
| Plant, machinery and equipment23 | - | €1,204 | €1,058 | €912 | €766 | ▼ 16.0% |
| Furniture and vehicles24 | - | €6,880 | - | €1,439 | €77,469 | ▲ 5,283% |
| Financial fixed assets28 | €25 | €25 | €25 | €25 | €25 | = |
| Current assets29/58 | €85,850 | €77,387 | €71,797 | €63,828 | €90,660 | ▲ 42.0% |
| Amounts receivable within one year40/41 | €2,181 | €8,373 | €15,310 | €17,047 | €45,276 | ▲ 166% |
| Trade receivables40 | - | - | - | €2,000 | €22,810 | ▲ 1,040% |
| Other amounts receivable41 | - | €8,373 | €15,310 | €15,047 | €22,467 | ▲ 49.3% |
| Cash at bank and in hand54/58 | €48,546 | €41,626 | €43,255 | €35,896 | €42,561 | ▲ 18.6% |
| Deferred charges and accrued income490/1 | - | €27,388 | €13,232 | €10,885 | €2,822 | ▼ 74.1% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €147,166 | €119,497 | €94,881 | €76,204 | €272,420 | ▲ 257% |
| Equity10/15 | €35,328 | €26,102 | €18,068 | €22,748 | €47,691 | ▲ 110% |
| Contributions10/11 | - | €6,200 | €6,200 | €18,600 | €18,600 | = |
| Reserves13 | €29,128 | €29,128 | €29,128 | €29,128 | €29,128 | = |
| Non-distributable reserves130/1 | - | €1,860 | €1,860 | - | - | - |
| Reserves not available under the articles1311 | - | €1,860 | €1,860 | - | - | - |
| Distributable reserves133 | - | €27,268 | €27,268 | €29,128 | €29,128 | = |
| Profit (loss) carried forward14 | - | -€9,225 | -€17,259 | -€24,980 | -€37 | ▲ 99.9% |
| Amounts payable17/49 | €111,839 | €93,394 | €76,812 | €53,456 | €224,730 | ▲ 320% |
| Amounts payable after more than one year17 | €49,781 | €31,691 | €17,081 | €3,451 | €43,812 | ▲ 1,169% |
| Financial debts170/4 | - | €31,691 | €17,081 | €3,451 | €43,812 | ▲ 1,169% |
| Amounts payable within one year42/48 | €61,955 | €61,623 | €59,674 | €49,972 | €180,909 | ▲ 262% |
| Current portion of amounts payable after more than one year42 | - | €19,167 | €15,710 | €14,753 | €20,144 | ▲ 36.5% |
| Trade debts44 | €3,362 | €2,175 | €2,993 | €2,470 | €15,871 | ▲ 543% |
| Suppliers440/4 | - | €2,175 | €2,993 | €2,470 | €15,871 | ▲ 543% |
| Taxes, remuneration and social security45 | - | €5,650 | €5,650 | €5,083 | €10,630 | ▲ 109% |
| Taxes450/3 | - | €1,986 | €1,945 | €2,366 | €10,630 | ▲ 349% |
| Remuneration and social security454/9 | - | €3,664 | €3,705 | €2,717 | - | - |
| Other amounts payable47/48 | - | €34,631 | €35,321 | €27,666 | €134,264 | ▲ 385% |
| Accrued charges and deferred income492/3 | - | €80 | €56 | €33 | €8 | ▼ 74.7% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €13,856 | -€9,225 | -€8,034 | -€7,720 | €24,943 | ▲ 423% |
| + Depreciation and write-downs630 | €19,490 | €19,207 | €19,026 | €12,407 | €40,843 | ▲ 229% |
| Operating cash flow (approximation) | €33,346 | €9,982 | €10,992 | €4,686 | €65,786 | ▲ 1,304% |
| Investment in fixed assets (approximation) | - | €0 | €0 | -€1,700 | -€210,227 | ▼ 12,266% |
| Change in cash | - | -€6,920 | €1,629 | -€7,359 | €6,665 | ▲ 191% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
31-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 31 days late
2024
31-12
Financial
Back to profitnet €24,943
Net result €24,943 after 3 loss-making years.
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
29-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 60 days late
2022
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-12
Financial
Weakest financial yearnet -€9,225
Net result drops to -€9,225, the lowest in the series; recovery starts the following year.
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
08-11
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 100 days late
2019
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 30 days late
2018
30-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 30 days late
2017
31-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 31 days late
2016
23-08
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 23 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Profondeville · 2 establishment units since 2014
Ground area
3.5 ha
Building footprint
7,059 m²
Volume, LiDAR
1,440 m³
3 parcels, Wallonia · tallest building 12.3 m, ±4 floors. Linked by address, not a title deed.
2 establishment units
CLINIQUE SAINTE ELISABETH
since 20142.236.736.262
CHU DINANT-GODINNE-UCL
since 20142.236.736.361
3 parcels
Wallonia
3
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 91034B0177/00Y003 | Wallonia | 3.3 ha | 1 · 6,883 m² | - |
| 91113A0480/00P002 | Wallonia | 1,173 m² | 1 · 139 m² | 10.1 m · 2 fl. |
| 92302G0574/00P005 | Wallonia | 53 m² | 1 · 38 m² | 12.3 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
3 of 3 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
PNEUMOLOGIE TILLEGEM
BE 0735.959.883
Brugge · Eq €47,776
ANEPSY
BE 0892.875.892
Sint-Lambrechts-Woluwe · Eq €47,801
DR. YOURI TAES - ENDOCRINOLOGIE
BE 0760.366.271
Merelbeke-Melle · Eq €47,566
ND-DERMATO
BE 0736.568.510
Antwerpen · Eq €47,565
CC ENDOCRINOLOGIE
BE 1015.666.016
Neupré · Eq €47,508
Of 16,631 companies in sector 86220 we hold annual accounts for 7,983. 4,996 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded13-11-2014
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0567762873
Registered
22-09-2025
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.